Di Lello Federico A, Culasso Andrés C A, Campos Rodolfo H
Cátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina Consejo Nacional de Investigaciones Científicas y Técnicas CONICET.
Cátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas CONICET.
Ann Hepatol. 2015 Jul-Aug;14(4):442-9.
Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in real-time. In this review, we discuss the implications to study HCV evolution at the interpatient and intrapatient levels of infection. The HCV interpatient dynamics is relatively slow, because the generation time is generally long. Then, at population level, the HCV diversity originated by the high mutation and replication rates is modulated by the bottleneck at transmission. Thus, when the virus is transmitted to other hosts, viral diversity is reduced as a result of the founder effect. On the other hand, during intrapatient infection, HCV evolves rapidly, resulting in quasispecies. Accumulated evidence suggests that this quasispecies composition of the HCV population within the same individual may allow the virus to evade the immune response or escape treatment, leading to chronic infection. Thus, a better understanding of the complexities underlying the molecular evolution of HCV in natural populations is needed before accurate predictions of viral evolution can be made. In summary, HCV evolves both within and among patients. Consequently, HCV evolution should be studied at both levels in order to better understand the natural history of the virus and its potential implications in epidemiology, outcome of infection and progression of liver disease.
丙型肝炎病毒(HCV)复制时间短、突变率高且群体规模大,所有这些使其成为进化研究的理想实验模型,因为进化过程可以实时观察到。在本综述中,我们讨论了在患者间和患者内感染水平上研究HCV进化的意义。HCV在患者间的动态变化相对缓慢,因为其世代时间通常较长。然后,在群体水平上,由高突变率和复制率产生的HCV多样性受到传播瓶颈的调节。因此,当病毒传播到其他宿主时,由于奠基者效应,病毒多样性会降低。另一方面,在患者内感染期间,HCV快速进化,形成准种。越来越多的证据表明,同一患者体内HCV群体的这种准种组成可能使病毒逃避免疫反应或逃脱治疗,从而导致慢性感染。因此,在能够准确预测病毒进化之前,需要更好地理解自然群体中HCV分子进化背后的复杂性。总之,HCV在患者体内和患者之间都会进化。因此,应该在这两个层面研究HCV进化,以便更好地理解病毒的自然史及其在流行病学、感染结果和肝病进展中的潜在影响。